SCHEMBL5376315

SCHEMBL5376315

NC(=O)c1cc(N2CCCCC2Cc2ccccc2)c2cc[nH]c2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.43
SLC6A3 Q01959 4/20 0.43
SLC6A2 P23975 3/20 0.40
ROCK2 O75116 2/20 0.40
ROCK1 Q13464 2/20 0.40
CDC42BPB Q9Y5S2 2/20 0.40
JAK2 O60674 3/20 0.40
JAK3 P52333 3/20 0.40
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
ATM Q13315 6/20 0.39
PIK3C3 Q8NEB9 4/20 0.39
ATR Q13535 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
PRKDC P78527 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5412862 0.77 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2ROCK2ROCK1
SCHEMBL5410852 0.68 ATM (0.40) SLC6A4SLC6A3ATMGABRA1GABRG2
SCHEMBL5735088 0.66 GABRA1 (0.41) SLC6A4SLC6A3SLC6A2ROCK2ROCK1
SCHEMBL18043464 0.66 HCRTR1 (0.37) SLC6A4SLC6A3ROCK2ROCK1CDC42BPB
SCHEMBL6429540 0.65 HSD11B1 (0.58) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL12505423 0.64 GFER (0.51)
SCHEMBL6192056 0.63 HSD11B1 (0.47) PARP14
SCHEMBL21138521 0.63 HSD11B1 (0.62)
SCHEMBL4964339 0.62 HSD11B1 (0.61) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL4629395 0.62 HSD11B1 (0.61) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed